Literature DB >> 29296890

The lipid peroxidation product 4-hydroxy-2-nonenal induces tissue factor decryption via ROS generation and the thioredoxin system.

Shabbir A Ansari1, Usha R Pendurthi1, L Vijaya Mohan Rao1.   

Abstract

Many pathophysiologic agents transform cryptic tissue factor (TF) on cells to prothrombotic TF, and one such stimulus is 4-hydroxy-2-nonenal (HNE), the most abundant aldehyde produced by the oxidation of ω-6 polyunsaturated fatty acids. HNE was shown to induce reactive oxygen species (ROS) generation and p38 MAPK activation, but the link between them and their role in TF decryption are unclear. The present study was carried out to elucidate potential mechanisms involved in HNE-induced TF decryption in monocytic cells. The data presented herein show that mitochondria are the primary source for HNE-induced ROS generation. The inhibition of mitochondrial electron transport chain complex III and V blocked HNE-induced ROS generation, but not p38 MAPK activation. These inhibitors reduced phosphatidylserine (PS) externalization and TF decryption significantly, but not completely. HNE treatment inhibited the activities of thioredoxin reductase (TrxR) and thioredoxin (Trx), independent of ROS. Inhibition of the TrxR/Trx system by HNE or pharmacological inhibitors induced p38 MAPK activation, PS externalization, and TF decryption. Additional studies revealed that the inhibition of TrxR/Trx led to activation of apoptosis signal-regulating kinase (ASK-1) and mitogen-activated protein kinase kinase 3/6. Inhibition of ASK-1 expression by small interfering RNA or its activity by pharmacological inhibitors diminished HNE-induced TF decryption. Overall, our data suggest that HNE induces TF decryption by 2 distinctive pathways. One is ROS dependent but independent of p38 MAPK activation, and the other is via TrxR/Trx and is p38 MAPK activation dependent. However, both mechanisms result in the enhancement of PS at the outer leaflet that is responsible for TF decryption.

Entities:  

Year:  2017        PMID: 29296890      PMCID: PMC5729625          DOI: 10.1182/bloodadvances.2017010132

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  40 in total

Review 1.  Oxidant sensing by reversible disulfide bond formation.

Authors:  Claudia M Cremers; Ursula Jakob
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

2.  Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure.

Authors:  Narcis I Popescu; Cristina Lupu; Florea Lupu
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

3.  Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase.

Authors:  David L Carbone; Jonathan A Doorn; Zachary Kiebler; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2005-08       Impact factor: 3.739

Review 4.  The thioredoxin superfamily in oxidative protein folding.

Authors:  Jun Lu; Arne Holmgren
Journal:  Antioxid Redox Signal       Date:  2014-03-06       Impact factor: 8.401

5.  Disulfide isomerization switches tissue factor from coagulation to cell signaling.

Authors:  Jasimuddin Ahamed; Henri H Versteeg; Marjolein Kerver; Vivien M Chen; Barbara M Mueller; Philip J Hogg; Wolfram Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-07       Impact factor: 11.205

Review 6.  Diabetes, oxidative stress, and antioxidants: a review.

Authors:  A C Maritim; R A Sanders; J B Watkins
Journal:  J Biochem Mol Toxicol       Date:  2003       Impact factor: 3.642

Review 7.  Role of oxidative stress in atherosclerosis.

Authors:  David Harrison; Kathy K Griendling; Ulf Landmesser; Burkhard Hornig; Helmut Drexler
Journal:  Am J Cardiol       Date:  2003-02-06       Impact factor: 2.778

8.  Oxidative stress in sepsis: a redox redux.

Authors:  Jay K Kolls
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

9.  Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation.

Authors:  Christoph Reinhardt; Marie-Luise von Brühl; Davit Manukyan; Lenka Grahl; Michael Lorenz; Berid Altmann; Silke Dlugai; Sonja Hess; Ildiko Konrad; Lena Orschiedt; Nigel Mackman; Lloyd Ruddock; Steffen Massberg; Bernd Engelmann
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  Inactivation of factor VIIa by antithrombin in vitro, ex vivo and in vivo: role of tissue factor and endothelial cell protein C receptor.

Authors:  Rit Vatsyayan; Hema Kothari; Nigel Mackman; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

View more
  10 in total

1.  Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma.

Authors:  Xiaolong Tang; Longzhou Chen; Amin Li; Shiyu Cai; Yinci Zhang; Xueke Liu; Zhenyou Jiang; Xinkuang Liu; Yong Liang; Dong Ma
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

2.  Oxidized Perilla and Linseed Oils Induce Neuronal Apoptosis by Caspase-Dependent and -Independent Pathways.

Authors:  Yuki Ueno; Yoshiyuki Kawamoto; Yamato Nakane; Risa Natsume; Kyoko Miura; Yui Okumura; Takashi Murate; Emi Hattori; Toshihiko Osawa
Journal:  Foods       Date:  2020-04-26

3.  Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy.

Authors:  Yuji Otsuki; Juntaro Yamasaki; Kentaro Suina; Shogo Okazaki; Naoyoshi Koike; Hideyuki Saya; Osamu Nagano
Journal:  Cancer Sci       Date:  2019-11-22       Impact factor: 6.716

4.  The procoagulant activity of tissue factor expressed on fibroblasts is increased by tissue factor-negative extracellular vesicles.

Authors:  Marcela Rosas; David A Slatter; Samya G Obaji; Jason P Webber; Jorge Alvarez-Jarreta; Christopher P Thomas; Maceler Aldrovandi; Victoria J Tyrrell; Peter V Jenkins; Valerie B O'Donnell; Peter W Collins
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

5.  Lidocaine Alleviates Sepsis-Induced Acute Lung Injury in Mice by Suppressing Tissue Factor and Matrix Metalloproteinase-2/9.

Authors:  Binbin Zheng; Hongbo Yang; Jianan Zhang; Xueli Wang; Hao Sun; Fan Hu; Qian Li; Liping Jiang; Yue Su; Qilin Peng; Yulin Tang; Wen-Tao Liu; Xueming He; Yixin Fan; Xia Zhu
Journal:  Oxid Med Cell Longev       Date:  2021-11-12       Impact factor: 6.543

Review 6.  Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  Br J Cancer       Date:  2022-09-12       Impact factor: 9.075

Review 7.  Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview.

Authors:  Débora Levy; Cadiele Oliana Reichert; Sérgio Paulo Bydlowski
Journal:  Antioxidants (Basel)       Date:  2019-05-02

8.  Platelet P-selectin triggers rapid surface exposure of tissue factor in monocytes.

Authors:  Ivelin I Ivanov; Bonita H R Apta; Arkadiusz M Bonna; Matthew T Harper
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

Review 9.  Factors Affecting the Formation and Treatment of Thrombosis by Natural and Synthetic Compounds.

Authors:  Anna Lichota; Eligia M Szewczyk; Krzysztof Gwozdzinski
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

10.  Oxidative Stress Product, 4-Hydroxy-2-Nonenal, Induces the Release of Tissue Factor-Positive Microvesicles From Perivascular Cells Into Circulation.

Authors:  Shabbir A Ansari; Shiva Keshava; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-08       Impact factor: 8.311

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.